Skip to main content

Main menu

  • Home
  • Articles
    • Current issue
    • Archive
    • Lung Science Conference 2017
  • About
    • About continuous publication
    • Journal information
    • Editorial board
    • Reviewers
    • Press office
    • Permissions and reprints
    • Advertising
    • Sponsorship
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
  • For readers
    • Alerts
    • Subjects
    • RSS
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Articles
    • Current issue
    • Archive
    • Lung Science Conference 2017
  • About
    • About continuous publication
    • Journal information
    • Editorial board
    • Reviewers
    • Press office
    • Permissions and reprints
    • Advertising
    • Sponsorship
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
  • For readers
    • Alerts
    • Subjects
    • RSS
  • Subscriptions

Pulmonary pharmacology and therapeutics

  • Pulmonary pharmacology and therapeutics
  • A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators
    Stefano Ponzano, Giulia Nigrelli, Laura Fregonese, Irmgard Eichler, Fabio Bertozzi, Tiziano Bandiera, Luis J.V. Galietta, Marisa Papaluca
    European Respiratory Review Jun 2018, 27 (148) 170124; DOI: 10.1183/16000617.0124-2017
  • How best to capture the respiratory consequences of prematurity?
    Francesca Ciuffini, Colin F. Robertson, David G. Tingay
    European Respiratory Review Mar 2018, 27 (147) 170108; DOI: 10.1183/16000617.0108-2017
  • Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
    Arnaud Boyer, Eddy Pasquier, Pascale Tomasini, Joseph Ciccolini, Laurent Greillier, Nicolas Andre, Fabrice Barlesi, Celine Mascaux
    European Respiratory Review Mar 2018, 27 (147) 170098; DOI: 10.1183/16000617.0098-2017
  • Pulmonary arterial hypertension: tailoring treatment to risk in the current era
    Sean Gaine, Vallerie McLaughlin
    European Respiratory Review Dec 2017, 26 (146) 170095; DOI: 10.1183/16000617.0095-2017
  • Long-term macrolides in diffuse interstitial lung diseases
    Paola Faverio, Francesco Bini, Adriano Vaghi, Alberto Pesci
    European Respiratory Review Dec 2017, 26 (146) 170082; DOI: 10.1183/16000617.0082-2017
  • Inhaler technique: does age matter? A systematic review
    Sarah Barbara, Vicky Kritikos, Sinthia Bosnic-Anticevich
    European Respiratory Review Dec 2017, 26 (146) 170055; DOI: 10.1183/16000617.0055-2017
  • Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
    Lisa H. Lancaster, Joao A. de Andrade, Joseph D. Zibrak, Maria L. Padilla, Carlo Albera, Steven D. Nathan, Marlies S. Wijsenbeek, John L. Stauffer, Klaus-Uwe Kirchgaessler, Ulrich Costabel
    European Respiratory Review Dec 2017, 26 (146) 170057; DOI: 10.1183/16000617.0057-2017
  • Personalised medicine for nonsmall cell lung cancer
    Céline Mascaux, Pascale Tomasini, Laurent Greillier, Fabrice Barlesi
    European Respiratory Review Dec 2017, 26 (146) 170066; DOI: 10.1183/16000617.0066-2017
  • Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease
    Rana Kanaan, Charlie Strange
    European Respiratory Review Dec 2017, 26 (146) 170061; DOI: 10.1183/16000617.0061-2017
  • When to start and when to stop antifibrotic therapies
    Sebastiano Emanuele Torrisi, Mauro Pavone, Ada Vancheri, Carlo Vancheri
    European Respiratory Review Sep 2017, 26 (145) 170053; DOI: 10.1183/16000617.0053-2017

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Acute lung injury and critical care (21)
  • Asthma and allergy (58)
  • CF and non-CF bronchiectasis (14)
  • COPD and smoking (58)
  • Epidemiology, occupational and environmental lung disease (33)
  • Genetics (17)
  • Interstitial and orphan lung disease (142)
  • Lung biology and experimental studies (14)
  • Lung cancer (41)
  • Lung imaging (17)
  • Lung structure and function (14)
  • Mechanisms of lung disease (54)
  • Paediatric pulmonology (15)
  • Pulmonary pharmacology and therapeutics (66)
  • Pulmonary vascular disease (134)
  • Respiratory clinical practice (85)
  • Respiratory infections and tuberculosis (27)
  • Sleep medicine (15)

Custom Text goes here

  • Most Read
  • Twitter
Loading
  • Rheumatoid arthritis-associated lung disease
  • Exacerbations of COPD
  • Differential diagnosis of granulomatous lung disease: clues and pitfalls
  • Immunological and toxicological risk assessment of e-cigarettes
  • Spontaneous pneumothorax: epidemiology, pathophysiology and cause
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Collections
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Fax: +44 114 266 5064
Email: info@ersj.org.uk

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2018 by the European Respiratory Society